Liberini, V.; Rubatto, M.; Mimmo, R.; Passera, R.; Ceci, F.; Fava, P.; Tonella, L.; Polverari, G.; Lesca, A.; Bellò, M.;
et al. Predictive Value of Baseline [18F]FDG PET/CT for Response to Systemic Therapy in Patients with Advanced Melanoma. J. Clin. Med. 2021, 10, 4994.
https://doi.org/10.3390/jcm10214994
AMA Style
Liberini V, Rubatto M, Mimmo R, Passera R, Ceci F, Fava P, Tonella L, Polverari G, Lesca A, Bellò M,
et al. Predictive Value of Baseline [18F]FDG PET/CT for Response to Systemic Therapy in Patients with Advanced Melanoma. Journal of Clinical Medicine. 2021; 10(21):4994.
https://doi.org/10.3390/jcm10214994
Chicago/Turabian Style
Liberini, Virginia, Marco Rubatto, Riccardo Mimmo, Roberto Passera, Francesco Ceci, Paolo Fava, Luca Tonella, Giulia Polverari, Adriana Lesca, Marilena Bellò,
and et al. 2021. "Predictive Value of Baseline [18F]FDG PET/CT for Response to Systemic Therapy in Patients with Advanced Melanoma" Journal of Clinical Medicine 10, no. 21: 4994.
https://doi.org/10.3390/jcm10214994
APA Style
Liberini, V., Rubatto, M., Mimmo, R., Passera, R., Ceci, F., Fava, P., Tonella, L., Polverari, G., Lesca, A., Bellò, M., Arena, V., Ribero, S., Quaglino, P., & Deandreis, D.
(2021). Predictive Value of Baseline [18F]FDG PET/CT for Response to Systemic Therapy in Patients with Advanced Melanoma. Journal of Clinical Medicine, 10(21), 4994.
https://doi.org/10.3390/jcm10214994